newsfilter
← Latest News
GlobeNewswire·

CENTOGENE Reports First Half 2023 Financial Results

First half 2023 total revenues with double-digit growth of 15.1% at €24.6 millionBoth Pharma and Diagnostics segments deliver strong performance, reaffirming full year 2023 guidance for total revenue growth between 10%